Sars, Cov-II Influenza A influenza B Nucleic Acidum combined

Short description:

Hoc ornamentum est idoneam in vitro qualitative deprehendatur Sars-Cov-II, influenza A et Influenza B Nucleic Acidum in Nasopharyngeal Swab et Oropharyngeum Sars, Cov B.


Product Detail

Product Tags

Product Name

HWTS, RT060A-Sars-Cov-II Influenza A Influenza B Nucleic Acidum combined dependenda Kit (Fluorence PCR)

Certificatorium

AKL / TGA / CE

Epidemiology

Corona Virus Morbus MMXIX (CoviD-XIX) est causa per Sars-Cov- II, quod pertinet ad β coronavirus de genere. Covi-XIX est acutus respiratorii infectious morbus et turba plerumque susceptibilis. In praesens, in Sars-Cov-II inficiuntur aegris sunt principalis fons infectio, et asymptomatic aegros potest etiam facti fons infectio. Ex in hodiernae epidemiological inquisitionis, in incubitu tempus est 1-14 dies, plerumque 3-7 diebus. Pelagus manifestationes febricitantem, arida tussis et lassitudine. A paucis aegris ut symptoms ut nasi obstructio, liquescit naribus, faucium, Myalgia et fluxus.

Influenza est acutus respiratoria infectio per influenza virus. Est altus infectious et diffundit maxime per tussis et sternumentum. Solet erumpit in fonte et hiems. Sunt tria genera influenza, influenza a (ifv a), influenza B (ifv b) et influenza C (ifv c), tam ex illis quae ad OrtomyXovirus familia. Influenza A et B, qui sunt unius, segny RNA virus, sunt principalis causas humani morborum. Influenza A est acutus respiratorii infectious morbus, inter H1N1, H3N2 et alia subtypes, est facile ad mutationem. In global tumultu, "subcinctus" refertur ad mutationem de influenza a, unde in novam virales "subtype". Influenza B dividitur in duas linagages: Yamagata et Victoria. Influenza B habent solum antigenic egisse, et evadere custodia et eliminanda humana immune ratio per mutationem. Sed influenza B Viruses evolve tardius quam humana influenza a, quae etiam causa respiratorii infectiones et epidemics in hominibus.

Channel

Fam

SARS-CoV-2

ROX

Ifv b

CYV

Ifv est

Vic (Hex)

Internum imperium genes

Technical parametri

Repono

Liquid: ≤, XVIII ℃ in tenebris

Lyophilization: ≤30 ℃ in tenebris

PLUTEUM-vitae

Liquid: IX mensibus

Lyophilization: XII mensibus

Specimen Type

Nasopharyngeal Swabs, Oropharyngeal Swabs

Ct

≤38

CV

≤5.0%

LOD

CCC copies / ml

Specifica

Crucis test eventus ostendit quod ornamentum est compatible cum humana coronavirus Sarsr- Cov, Mersr-Cov, HCOV-OC43, HCOV-229E, HCOV-Hc43, HCOV-NL63, HCOV-HCV, HCOV, NL63, Viris I, II III, Rhinovirusa, B et C, adenovirus I, II, III, IV, V, VII et LV, Metapneumovirus VII, B, C et D, Humanum Cytoplasmic pulmonalis virus, EB virus, virus humana Cytomegalovirus, Rotavirus, Norovirus, Mycoplasma, Mycoplasma, Chlamydia, Mycoplasma Pneumoniae, Chlamydia Pneumoniae, Legionella, Pertussis, Haemophilus influenzae, Staphylococcus Aureus, Streptococcus Pseumoniae, Streptococcus pyogenes, Klebsiella Pneumoniae, Mycobacterium, Aspergillus Fumigatus, Candida Albicans, Candida Yersini et crucem reactionem inter Pneumocystis Yersini CryptoCococcus Neoformans.

Applicabiles instrumenta:

Potest aequare amet fluorescent PCR instrumenta in foro.

Applicari Biosystems (VII) D Real-vicis PCR Systems

Applicari Biosystems (VII) D ieiunium realis-vicis PCR systems

QuantStudio®5 Real-vicis PCR Systems

Slan-96P realis-vicis PCR systems

LightcyCler®®®® Real-vicis PCR ratio

Linenene (IX) DC plus realis-vicis PCR deprehensio ratio

MA-(VI) Real-vicis quantitatis scelerisque cycler

BIOD CFX96 Real-vicis PCR ratio

BIOD CFX Opus XCVI Real-vicis PCR ratio

ADMODO

Optio I.

Commendatur extraction Reagent: Macro & Micro-test viral DNA / RNA Kit (HWTS-MMMCI, HWTS-3004-32, HWTS-3004-48) et Macro-Test Automatic Nucleiic Acidum extractor (HWTS-MMMVI).

Optio II.

Commendatur extraction Reagent: nucleic acidum extractionem et purificationem Reagent (ydp302) by Tiangen Biotech (Beijing) Co., Ltd.


  • Previous:
  • Next:

  • Scribere nuntium hic mitte nobis